Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RCKT

Rocket Pharmaceuticals Inc

May 22 • 04:00PM ET

2.96

-0.15 -4.82 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: RGNX VYGR QURE EDIT SLDB

| Held by: VTI XBI IWM VXF IBB IWN VTWO FESM SCHA DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.88	Insider Own	5.17%	Shs Outstand	109.12M	Perf Week	-8.92%
Market Cap	323.21M	Forward P/E	-	EPS next Y	-1.28	Insider Trans	-0.96%	Shs Float	103.55M	Perf Month	-19.57%
Enterprise Value	203.59M	PEG	-	EPS next Q	1.02	Inst Own	89.46%	Short Float	20.81%	Perf Quarter	-25.81%
Income	-209.38M	P/S	-	EPS this Y	85.64%	Inst Trans	5.94%	Short Ratio	6.33	Perf Half Y	2.78%
Sales	0.00M	P/B	1.36	EPS next Y	-341.97%	ROA	-55.36%	Short Interest	21.55M	Perf YTD	-15.67%
Book/sh	2.18	P/C	2.24	EPS next 5Y	22.83%	ROE	-64.41%	52W High	6.80 -56.47%	Perf Year	-54.88%
Cash/sh	1.32	P/FCF	-	EPS past 3/5Y	14.88% 4.46%	ROIC	-80.57%	52W Low	2.19 35.16%	Perf 3Y	-86.49%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.39% 6.99%	Perf 5Y	-92.87%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	28.56%	Oper. Margin	-	ATR (14)	0.24	Perf 10Y	-91.82%
Dividend Ex-Date	-	Quick Ratio	6.12	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	34.25	Recom	2.43
Dividend Gr. 3/5Y	- -	Current Ratio	6.12	EPS Q/Q	23.82%	SMA20	-13.27%	Beta	0.50	Target Price	9.30
Payout	-	Debt/Eq	0.10	Sales Q/Q	-	SMA50	-20.67%	Rel Volume	0.62	Prev Close	3.11
Employees	202	LT Debt/Eq	0.09	Earnings	May 07 AMC	SMA200	-17.14%	Avg Volume	3.40M	Price	2.96
IPO	Feb 18, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-3.24% -	Trades		Volume	2,103,387	Change	-4.82%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)